Hos børn behandlet med Fabrazyme sås der også et fald i GL- 3- niveauet i blodet, mens niveauet hos alle børn var normalt efter 20 ugers behandling.
Children treated with Fabrazyme also had decreases in levels of GL-3 in the blood, with all children having normal levels after 20 weeks of treatment.